Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

205
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
205
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

194
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
194
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

3.9K
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
3.9K
Infection01:20

Infection

6.5K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
6.5K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

10.6K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
10.6K
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

2.8K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Importance of Residency Training for the Provision of Comprehensive Clinical Pharmacy Services.

Journal of the American College of Clinical Pharmacy : JACCP·2026
Same author

Comment on "Adopting Race-Free Estimated Glomerular Filtration Rate for Unifying Medication-Related Decision-Making: An Opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy".

Journal of the American College of Clinical Pharmacy : JACCP·2026
Same author

Ceftriaxone dosing in thrice-weekly hemodialysis.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2025
Same author

Low-dose Buprenorphine Initiation in Pregnancy: A Systematic Review.

Journal of addiction medicine·2025
Same author

Association Between Erythromycin or Clindamycin Resistance and 30-Day Mortality in Patients With MSSA Bacteremia.

Journal of pharmacy practice·2025
Same author

Dalbavancin Use in Persons Who Use Drugs May Increase Adherence Without Increasing Cost.

The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians·2024
Same journal

Cinnamon-Derived Compounds Reduce PD-L1 Expression in UV-Exposed Human Skin Cell Line.

Medicines (Basel, Switzerland)·2026
Same journal

Narrative Review of Novel Nicotine-Delivery Systems and Emerging Pharmaceuticals for Tobacco Cessation.

Medicines (Basel, Switzerland)·2026
Same journal

Treatment of Methicillin-Resistant <i>Staphylococcus aureus</i> (MRSA) Bacteremia-Guidelines and Recent Developments.

Medicines (Basel, Switzerland)·2026
Same journal

Sulforaphane Synergies with Phytochemicals and Pharmaceuticals: Implications for Healthspan.

Medicines (Basel, Switzerland)·2026
Same journal

The Efficacy of Fixed-Dose Diclofenac and Orphenadrine for Postoperative Pain Management: A Systematic Review.

Medicines (Basel, Switzerland)·2026
Same journal

Evidence and Tradition in Dialogue: Biological Sex Variability in Phytomedicine Research as a Foundation for Safety, Efficacy, and Robust Evidence Standards.

Medicines (Basel, Switzerland)·2026
See all related articles

Related Experiment Video

Updated: May 10, 2025

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA

Published on: February 9, 2011

22.9K

Common Bacterial Infections in Persons Who Inject Drugs.

Michael P Lorenzo1, Kathleen K Adams2, Seth T Housman1,3

  • 1Baystate Medical Center, Springfield, MA 01199, USA.

Medicines (Basel, Switzerland)
|April 23, 2025
PubMed
Summary
This summary is machine-generated.

Opioid use leads to increased bacterial infections in people who inject drugs (PWID). Addressing care disparities through optimal pharmacotherapy and management strategies can improve patient outcomes.

Keywords:
endocarditisinfectionsopioid use disorder

More Related Videos

Author Spotlight: Enhancing Candida albicans Detection in Catheter Infections Using Fluorescent Protein Tagging
03:24

Author Spotlight: Enhancing Candida albicans Detection in Catheter Infections Using Fluorescent Protein Tagging

Published on: March 22, 2024

1.3K
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

12.8K

Related Experiment Videos

Last Updated: May 10, 2025

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA

Published on: February 9, 2011

22.9K
Author Spotlight: Enhancing Candida albicans Detection in Catheter Infections Using Fluorescent Protein Tagging
03:24

Author Spotlight: Enhancing Candida albicans Detection in Catheter Infections Using Fluorescent Protein Tagging

Published on: March 22, 2024

1.3K
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

12.8K

Area of Science:

  • Infectious Diseases
  • Public Health
  • Pharmacotherapy

Background:

  • Opioid use has surged in the United States, leading to a rise in bacterial infections.
  • Persons who inject drugs (PWID) face significant disparities in healthcare access and outcomes.
  • Poor health outcomes are frequently observed in PWID with bacterial infections.

Purpose of the Study:

  • To highlight the challenges in treating bacterial infections among PWID.
  • To emphasize the disparities in care experienced by PWID.
  • To advocate for improved pharmacotherapy and management strategies for PWID.

Main Methods:

  • Review of current literature on opioid use and infectious diseases.
  • Analysis of healthcare disparities in the PWID population.
  • Examination of pharmacotherapy and management approaches.

Main Results:

  • Bacterial infections are a prevalent complication of opioid use among PWID.
  • Significant disparities exist in the quality of care and health outcomes for PWID.
  • Current management strategies may not adequately address the needs of PWID.

Conclusions:

  • Healthcare providers must implement optimal pharmacotherapy for bacterial infections in PWID.
  • Adopting revised approaches to managing PWID is crucial for reducing disparities.
  • Improving care for PWID with infections can lead to better health outcomes.